Magenta therapeutics reports qtrly loss per share $0.54

Magenta therapeutics reports third quarter 2019 financial results and recent business highlights.ended quarter with $160.6 million in cash, cash equivalents and marketable securities.qtrly loss per share $0.54.q3 earnings per share view $-0.54 -- refinitiv ibes data.

DNTH Ratings Summary

DNTH Quant Ranking